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A B S T R A C T
Background: Differential diagnosis between bipolar disorder (BD) and borderline personality disorder
(BPD) is often challenging due to some overlap in symptoms and comorbidity of disorders. We
investigated correlations in self-reported symptoms of BD and BPD in screening questionnaires at the
levels of both total scores and individual items and explored overlapping dimensions.
Methods: The McLean Screening Instrument (MSI) for BPD and the Mood Disorder Questionnaire (MDQ)
for BD were filled in by patients with unipolar and bipolar mood disorders (n = 313) from specialized
psychiatric care within a pilot study of the Helsinki University Psychiatric Consortium. Pearson’s
correlation coefficients between total scores and individual items of the MSI and the MDQ were
estimated. Relationships between MDQ and MSI were evaluated by exploratory factor analysis (EFA).
Results: The correlation between total scores of the MDQ and MSI was moderate (r = 0.431, P < 0.001).
Significant correlations were found between the MSI items of ‘‘impulsivity’’ and ‘‘mood instability’’ and all
MDQ items (P < 0.01). In the EFA, the MSI ‘‘impulsivity’’ and ‘‘mood instability’’ items had significant cross-
loadings (0.348 and 0.298, respectively) with the MDQ factor. The MDQ items of ‘‘irritability’’, ‘‘flight of
thoughts’’ and ‘‘distractibility’’ (0.280, 0.210 and 0.386, respectively) cross-loaded on the MSI factor.
Conclusions: The MDQ and MSI items of ‘‘affective instability’’, ‘‘impulsivity’’, ‘‘irritability’’, ‘‘flight of
thoughts’’ and ‘‘distractibility’’ appear to overlap in content. The other scale items are more disorder-
specific, and thus, may help to distinguish BD and BPD.
 2015 Elsevier Masson SAS. All rights reserved.
Contents lists available at ScienceDirect
European Psychiatry
jo u rn al h om epag e: h t tp : / /ww w.eu ro p s y- jo ur n al .co m1. Introduction
Borderline personality disorder (BPD) is often comorbid with
mood disorders and shares some phenomenological features with
them, particularly with bipolar disorder (BD) [3]. This has resulted
in numerous discussions about relationship of the BPD with BD,
some authors even suggesting than BPD should be considered as a
part of the bipolar spectrum disorders [1], others emphasizing
differences between them [24]. Some recent studies have indicated
partial overlap in pathogenetic mechanisms and genetics of the
disorders, although clear distinctions have also been found* Corresponding author. Tel.: +358 9 4711; fax: +358 9 47163735.
E-mail address: erkki.isometsa@hus.fi (E. Isometsä).
1 Tel.: +358 9 4711.
2 Tel.: +358 9 4711; fax: +358 9 47163735.
3 Tel.: +358 9 4711; fax: +358 9 47175455.
4 Tel.: +358 40 1731112.
http://dx.doi.org/10.1016/j.eurpsy.2015.08.002
0924-9338/ 2015 Elsevier Masson SAS. All rights reserved.[6,31,32,34]. Phenomenological and neurobiological overlap may
underlie common difficulties in differential diagnosis between BPD
and BD. However, because of notable differences in their treatment
[24], it is important to distinguish the two disorders in psychiatric
and other clinical settings.
Numerous previous studies have found BD to be widely under-
recognized [11,17,25], or recognized only after a long delay
[17]. The same may be also true for BPD [19]. However, as BD has
received increasing clinical recognition and attention in recent
years, some reports have implied that BD also may also become
overdiagnosed at times and, moreover, patients misdiagnosed
with BD may be significantly more likely to be later diagnosed with
BPD [38–40]. There is a possibility of overdiagnosis of BPD, too.
In the absence of widely approved biomarkers specific for each
disorder, the diagnoses of BD and BPD remain clinical [18]. The
systematic use of screening tests and structured clinical interviews
may considerably improve detection of disorders in clinical
psychiatry [29]. The McLean Screening Instrument (MSI) for BPDs
I. Baryshnikov et al. / European Psychiatry 30 (2015) 914–919 915and the Mood Disorder Questionnaire (MDQ) for BD are useful and
valid screening instruments used in psychiatric settings to improve
recognition of these disorders. Both are based on self-reported
symptoms [11,12,36].
In this study, we aimed to investigate the correlation between
the MSI and the MDQ at the levels of both total scores and
individual items, and explore overlapping and non-overlapping
self-reported items of BD and BPD.
2. Methods
2.1. The Helsinki University Psychiatric Consortium (HUPC)
This investigation is a part of the Helsinki University Psychiatric
Consortium (HUPC) pilot study, a collaborative research project
between the faculty of medicine of the university of Helsinki; the
department of mental health and substance abuse services of the
National institute for health and welfare; the Department of social
services and health care, city of Helsinki; and the department of
psychiatry, university of Helsinki and Helsinki university hospital.
The study protocol was approved by the Ethics committee of
Helsinki university central hospital.
2.2. Setting
The study was conducted in 10 community mental health
centres, three psychiatric inpatient units and one day-hospital
offering specialized secondary public mental health services in the
metropolitan area of Helsinki between 12.1.2011 and 20.12.2012.
2.3. Sampling
Inclusion criteria for participation in the pilot study were
patients’ age of over 18 years and provision of informed consent.
Patients with mental retardation, neurodegenerative disorders and
insufficient Finnish language skills were excluded. Stratified
patient sampling selection was performed by identifying all
patients within a certain day or week in a unit or by randomly
drawing eligible patients from patient lists. Patients treated for
psychotic disorders, neuropsychiatric disorders and substance use
disorders were excluded from our study. Of the 902 eligible
patients with mood, neurotic or personality disorders, 372 declined
to participate and 216 were lost for other reasons.Table 1
Characteristics of MDQ and MSI responders (n = 313).
BD 
n % 
Number 99 32 
Age (mean) 43.7  12.7 
BPD 17 17.2 
Sex (male) 36 36.3 
Marital state
Married 20 20.2 
Cohabitation 17 17.2 
Unmarried 32 32.2 
Divorced 29 29.3 
Widowed 1 1 
Job
Retired due to mental disorder 37 37.4 
Unemployed 10 10 
Sick leave 22 22.2 
Retired due to another reason 1 1 
Student 7 7.1 
Employed 20 20.2 
Unemployed due to another reason 2 2.2 
BD: bipolar disorder; UD: unipolar depression; BPD: borderline personality; MDQ: Mo2.4. Clinical diagnoses
The validity of the clinical diagnoses assigned by the attending
physicians was critically evaluated by the authors (I.B., K.A., M.K.,
B.K.) by re-examining all available information from the patient
records. Authors K.A., I.B. and B.K. were residents of psychiatry
trained in diagnostic evaluations; in any unclear cases, the senior
psychiatrists (M.K., E.I., G.J., M.H.) were consulted. The validated
clinical diagnoses were based on the ICD-10-DCR [35]. Lifetime
principal diagnosis was assigned. Although there is no division of
BD into types I (BD-I) and II (BD-II) in the ICD-10, we subtyped
patients into these categories according to the DSM-IV [2]. This
distinction is established clinical practice in Finland and included
in the national BD treatment guidelines.
2.5. Description of patients
Altogether 313 patients participated in the study. Their mean
age was 41.7  13.1 years, and 229 (73.1%) were female. All patients
were allocated into groups according to the lifetime principal
diagnosis; (see Table 1). Patients comprised those with depressive
episode (F32-F33; future unipolar depression [UD] [n = 183; mean age
41.4  13.3 years]), bipolar affective disorder (F31; [n = 99, mean age
43.7  12.7 years]) and others (n = 31, mean age 36.2  13 years).
Among patients with BD, 36 (36.3%) had type I, 55 (55.5%) type II and 8
(8%) unspecified type. Fifteen patients with neurotic and somatoform
disorders, four patients with eating disorders, five patients with
dysthymia and seven patients with BPD as lifetime principal diagnosis
formed the group ‘‘others’’. There were 65 patients with BPD among
all patients, including patients with BPD as lifetime principal
diagnosis and as comorbid. Their mean age was 37.5  13 years.
The analysis of representativeness was undertaken by compar-
ing patients suffering from UD or BD in the HUPC with patients
with the same diagnoses treated in 2011 and 2012 in psychiatric
care organizations. No significant differences emerged in sex and
age between these two groups (data not shown).
2.6. Mood Disorder Questionnaire (MDQ)
The MDQ is a brief self-report instrument for screening
symptoms or behaviours related to a manic or hypomanic
syndrome [12], and it has been translated into Finnish [13]. The
first part of the MDQ includes 13 items requiring a ‘‘yes/no’’UD Others
n % n %
183 58 31 10
41.4  13.3 36.2  13
39 21.3 9 29
42 22.9 6 19.4
39 21.3 4 12.9
29 15.8 3 9.7
75 41 17 55
35 19.1 6 19.4
3 1.7 0 0
23 12.5 6 19.4
18 9.8 8 26
64 35 5 16.1
8 4.4 0 0
24 13.1 6 19.4
30 16.4 5 16.1
14 7.7 1 3.2
od Disorder Questionnaire; MSI: McLean Screening Instrument.
Table 2
Results MDQ and MSI questionnaires in patients (n = 313).
BD-I BD-II BD unspecified UD Others P*
MDQ mean 10.4  2.9 9.9  3.3 10  2.7 4.9  3.7 4.9  4.4 < 0.0001
MSI mean 5.1  2.6 6.3  2.3 7.6  2.7 5.5  2.7 5.2  2.5 0.030
MDQ positive, n (%) 27 (75) 34 (62) 7 (88) 34 (19) 7 (23) < 0.0001
MDQ negative, n (%) 9 (25) 21 (38) 1 (12) 149 (81) 24 (77) < 0.0001
MSI positive, n (%) 12 (31) 27 (49) 6 (75) 74 (39) 9 (5) 0.090
MSI negative, n (%) 24 (69) 28 (51) 2 (25) 109 (61) 22 (95) 0.090
BD-I: bipolar disorder type I; BD-II: bipolar disorder type II; UD: unipolar depression; BPD: borderline personality disorder; MDQ: Mood Disorder Questionnaire; MSI: McLean
Screening Instrument.
* P-values reflect differences between group of patients with bipolar disorder (I; II- or unspecified type) with groups of patients with unipolar depression and others.
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several of these symptoms have been experienced during the same
time period, and the third part asks about the severity of the
resulting problems. The screening is regarded as positive when
seven or more symptoms have occurred within the same episode,
causing moderate to severe problems. In the correlation analysis
only the first question’s responses were used; Cronbach’s alpha for
them was 0.89, indicating excellent internal consistency.
2.7. McLean Screening Instrument (MSI)
The MSI is a ten-item questionnaire designed to screen for BPD
[36]; it has been translated into Finnish [19]. Each item requires a
‘‘yes/no’’ response. Each positive item indicates the presence of
BPD symptoms. Previous research has suggested that a useful
clinical cut-off score in predicting BPD among adults is seven or
more. Cronbach’s alpha for MSI was 0.747, indicating a good
internal consistency.
2.8. Statistical analysis
Analyses were performed using the Mplus 7.1 software
[21]. Because the items were categorical, the WLSMV estimator
was used to estimate the models, and the model is effectively an
item-response theory (IRT) model with two factors (MDQ and
MSI). Potential cross-loadings were examined by looking at model
Modification Indexes, which are used to identify structural
misspecifications in the model. The correlation from 0.8 to
1 was considered as ‘‘very strong’’, from 0.6 to 0.79 as ‘‘strong’’,
from 0.40–0.59 as ‘‘moderate’’, from 0.20–0.39 as ‘‘weak’’ and less
than 0.2 as ‘‘very weak’’ [8].Table 3










Elevated mood 0.105 0.100 0.304** 0.381** 0.10
Irritability 0.281** 0.134* 0.277** 0.263** 0.23
Increased self-confidence 0.041 0.082 0.310** 0.328** 0.07
Decreased need for sleep 0.059 0.172** 0.254** 0.351** 0.10
Talkativeness 0.050 0.043 0.256** 0.277** 0.12
Flight of thoughts 0.018 0.047 0.276** 0.376** 0.12
Distractibility 0.023 0.083 0.175** 0.301** 0.17
Increased energy 0.124* 0.149** 0.358** 0.311** 0.15
Increased activity 0.092 0.118* 0.310** 0.311** 0.12
Increased sociality 0.026 0.058 0.229** 0.307** 0.07
Increased sexuality 0.080 0.112* 0.296** 0.327** 0.17
High risk behaviour 0.110 0.176** 0.260** 0.397** 0.10
Money spending 0.188** 0.141* 0.371** 0.339** 0.15
MDQ: Mood Disorder Questionnaire; MSI: McLean Screening Instrument.
* P < 0.05.
** P < 0.005.3. Results
3.1. MDQ and MSI scores
The BD patients scored significantly higher on the MDQ and fell
more often into MDQ positive category than their UD and ‘‘others’’
counterparts (see Table 2).
3.2. Correlation analysis
A moderate statistically significant correlation (r = 0.431,
P < 0.001) was found between the MDQ and MSI total scores.
Item-by-item correlations are shown in Table 3. More specifically,
the MSI items of ‘‘impulsivity’’ and ‘‘mood instability’’ correlated
significantly and coherently with all MDQ items, with r coefficients
ranging from 0.263 to 0.397.
3.3. Factor analysis
In the two-factor IRT model, all MDQ and MSI items predictably
loaded on their respective factors (all P < 0.01), Based on
Modification Indexes, two MSI items had significant cross-loadings
on the MDQ factor (both P < 0.01): ‘‘impulsivity’’ and ‘‘mood
instability.’’ Three MDQ items in turn had significant cross-
loadings with the MSI factor (all P < 0.01): ‘‘irritability’’, ‘‘flight of
thoughts’’, and ‘‘distractibility’’ (Fig. 1).
3.4. Correlation analysis in diagnostic subgroups
The correlation between the MDQ and MSI emerged indepen-








7 0.154** 0.178** 0.140* 0.100 0.069
7** 0.187** 0.066 –0.007 0.040 0.132*
9 0.139* 0.089 0.145** 0.066 0.118*
1 0.169** 0.206** 0.148** 0.058 0.088
7* 0.154* 0.146** 0.110 0.166** 0.140*
1* 0.142* 0.186** 0.163** 0.135* 0.026
8** 0.212** 0.310** 0.194** 0.188** 0.087
4** 0.112* 0.167** 0.087 0.080 0.128*
3* 0.115* 0.142* 0.082 0.065 0.096
4 0.132* 0.153* 0.171** 0.104 0.088
6** 0.078 0.085 0.133** 0.125* 0.044
9 0.121* 0.193** 0.120* 0.105 0.070
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Fig. 1. Factor analysis of MDQ and MSI. Solid arrows indicate the items receiving content from only one questionnaire; dashed arrows indicate the items receiving content
from both questionnaires. MDQ: Mood Disorder Questionnaire; MSI: McLean Screening Instrument.
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MSI and MDQ and details of item-by-item analysis are shown in
Table 4.
4. Discussion
We found a moderate correlation between total scores of self-
reported symptoms of bipolar disorder (BD) on the Mood Disorder
Questionnaire (MDQ) and borderline personality disorder (BPD) on
the McLean Screening Instrument (MSI) among patients withmood disorders treated in psychiatric specialized units. In the
item-by-item analysis, the most consistent correlation emerged
between the MSI items of ‘‘mood instability’’ and ‘‘impulsivity’’ and
all MDQ items. In the factor analysis, the items of ‘‘flight of
thoughts’’, ‘‘distractibility’’ and ‘‘irritability’’ appeared to overlap.
To our knowledge, this is the first study on the phenomenolog-
ical overlap between BP and BPD based on the self-report screening
instruments MSI and MDQ. Strengths of our study included the
relatively large number of patients and the representativeness of
mood disorder patients recruited from specialized psychiatric care.
However, there were also several limitations. First, the response
Table 4
Correlation analysis between the MDQ and MSI within diagnostic subgroups.
Subgroup n r between total
scores of MDQ
and MSI
Main findings from item-by-item analysis. Correlations were** as listed below
All patients with BP and BPD 147 0.274* Moderate between MSI ‘‘mood instability’’ and all MDQ items; weak between
MSI ‘‘impulsivity’’ and ‘‘irritability’’ and ‘‘money spending’’
BD with comorbid BPD 17 0.410* Strong between MSI ‘‘mood instability’’ and MDQ ‘‘elevated mood’’,
‘‘irritability’’; moderate between MSI ‘‘impulsivity’’ and MDQ ‘‘money
spending’’, ‘‘interpersonal disputes’’, ‘‘irritability’’
All patients with BD 99 0.349* Weak between MSI ‘‘mood instability’’ and all MDQ items
BD-I 36 0.296* Moderate between MDQ ‘‘irritability’’ and MSI ‘‘interpersonal disputes’’,
‘‘increased anger’’. Moderate between MSI ‘‘mood instability’’ and MDQ
‘‘decreased need for sleep’’, ‘‘flight of thoughts’’, ‘‘increased activity’’, etc.
BD-II 55 0.475* Moderate between MSI ‘‘mood instability’’ and all MDQ items. Moderate
between MSI ‘‘impulsivity’’ and ‘‘decreased need for sleep’’, ‘‘increased energy’’,
‘‘talkativeness’’, ‘‘increased self-confidence’’
BD without comorbid BPD 82 0.355* Weak or moderate between MSI ‘‘mood instability’’ and all MDQ items
UD and comorbid BPD 39 0.328* Weak between MSI ‘‘impulsivity’’ and MDQ ‘‘increased self-confidence’’,
‘‘talkativeness’’, ‘‘increased energy’’, etc. Moderate between MSI ‘‘mood
instability’’ and MDQ ‘‘irritability’’
UD without BPD 144 0.502* Weak between MSI ‘‘impulsivity’’ ‘‘mood instability’’ and all MDQ items
BPD 65 0.404* Moderate between MSI ‘‘mood instability’’; ‘‘impulsivity’’ and MDQ
‘‘irritability’’, ‘‘increased energy’’, ‘‘increased activity’’
Excluding group ‘‘others’’ 283 0.429* Weak or moderate between MSI ‘‘mood instability’’, ‘‘impulsivity’’ and all MDQ
items
BD: bipolar disorder; BD-I: bipolar disorder type 1; BD-II: bipolar disorder type 2; BPD: borderline personality disorder; UD: unipolar depression; MDQ: Mood Disorder
Questionnaire; MSI: McLean Screening Instrument.
* P < 0.005.
** r value not shown.
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routine service facilities. Nevertheless, the analysis of representa-
tiveness indicated no significant differences in terms of age or sex
between our cohort and the whole population of patients treated in
the years 2011 and 2012. Second, the clinical diagnoses were not
verified with structured clinical diagnostic interview instruments.
However, all patients had been diagnosed with mood disorders in
psychiatric settings specialized in their treatment, and all available
relevant diagnostic information on each patient was re-evaluated
by the authors. Moreover, the focus of this study was in responses
to screens, not diagnoses per se.
Problematic boundaries between BD and BPD as well as
difficulties in their differential diagnostics have been topics of
numerous discussions for a long time [1,16,23,24,37]. The moder-
ate correlation between the total scores of the screening
instruments MDQ and MSI indicates partial similarity in self-
reported features of BD and BPD. In the item-by-item analysis, the
MSI items of ‘‘mood instability’’ and ‘‘impulsivity’’ correlated
consistently with all MDQ items. Furthermore, for patients with
both BPD and BD, particularly BD type II, the correlation was shown
to be stronger than for other groups.
Mood instability and impulsivity are core features of BPD, but
both can also be observed in patients with BD [3,5,9,22,27]. Some
experts have postulated cyclothymic affective temperament to
underlie disorders of emotional regulation in both BPD and BD
[25,28]. Nevertheless, some distinctions in the nature of ‘‘affective
instability’’ and ‘‘impulsivity’’ in BD and BPD have been described
[4,9,10,14,15,22]. Our study indicates that the symptomatic
overlap between BD and BPD in ‘‘impulsivity’’ and ‘‘mood
instability’’ is also revealed in self-reports. Consequently, patients
with self-reported ‘‘impulsivity’’ and ‘‘mood instability’’ may score
higher on the MDQ even in the absence of bipolarity. On the other
hand, patients with a history of hypomania may score higher on
the MSI, leading to false interpretation of BPD.
Factor analysis revealed significant cross-loadings with five
items (see Fig. 1). As a result, a patient scoring high on the MSI may
also score high on the MDQ, probably due to difficulties indistinguishing from the hypomania items of ‘‘irritability’’, ‘‘flight of
thoughts’’ and ‘‘distractibility’’. Correspondingly, patients scoring
high on the MDQ may have increased MSI scores due to
misinterpretation of the MSI items of ‘‘mood instability’’ and
‘‘impulsivity’’. Thus, MSI and MDQ scores associate with each other
due to these symptoms, which may easily lead into erroneous
diagnostic conclusions, unless both aspects of psychopathology are
carefully evaluated.
The use of these screening instruments is based on the patient’s
own estimation of the presence or absence of symptoms. Several
factors may influence patients’ ability to answer to the scales
questions, including well described impairments in social
cognition [20,26,30], autobiographical memory disruptions
[7,33] and current mood, among others. Our results indicate an
overlap in the self-reported features of ‘‘flight of thoughts’’,
‘‘distractibility’’ and ‘‘irritability’’ on the MDQ and ‘‘mood
instability’’ and ‘‘impulsivity’’ on the MSI. Despite this overlap,
the majority of the other items on both questionnaires involve
specific features of each disorder, which can help to distinguish
between them.
Both the MDQ and MSI were created to improve recognition of a
specific disorder. When interpreting the results of screening it is
likely useful to evaluate how patient’s answers are distributed
between overlapping and non-overlapping items of the MDQ and
MSI. Even more important clinically is not to limit evaluation only
on one specific diagnostic tool, but to consider alternative
explanations for apparent psychopathology, and to conduct
careful, comprehensive clinical interviews to differentiate between
BPD and BD, or to ascertain their concurrent presence.
5. Conclusions
The MDQ and MSI measure partly the same dimensions in
patients with mood disorders. The self-reported symptoms of
‘‘affective instability’’, ‘‘impulsivity’’, ‘‘irritability’’, ‘‘flight of thoughts’’
and ‘‘distractibility’’ are shared and may lead to misinterpretations of
I. Baryshnikov et al. / European Psychiatry 30 (2015) 914–919 919screenings. However, non-overlapping items on both questionnaires
are more specific to the disorders for which they are designed, and
thus, could be given more weight in differential diagnosis.
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